Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.

导出 OA

翻译打印收藏纠错

第一作者： Jiali,Zhang

第一单位： Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

作者： Jiali,Zhang ^[1] ; Gefei,Li ^[1] ; Yuan,Chen ^[1] ; Lei,Fang ^[1] ; Chen,Guan ^[1] ; Fumao,Bai ^[1] ; Mengni,Ma ^[1] ; Jianxin,Lyu ^[1] ; Qing H,Meng ^[1]

作者单位： Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. ^[1] Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ^[2]

关键词 AKT2 Metformin breast cancer cell miR-200c

DOI 10.7150/jca.19858

PMID 28819383

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览57

Journal of Cancer

2017年8卷10期

1849-1864页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.

Journal of Cancer

相似文献

Journal of Cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.

Journal of Cancer

相似文献

Journal of Cancer

相关期刊

检索历史清除